Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Aimmune Therapeutics Inc. (AIMT)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Aisling Capital

Dennis Purcell

1,990,000 $54,287 -12% 11.73%
2.
Palo Alto Investors

William Leland Edwards

1,381,759 $37,694 1.52%
3.
Deerfield Management

James E. Flynn

553,000 $15,086 -18% 0.54%
4. 294,160 $8,025 +2% 0.44%
5.
Dorset Management

David M. Knott

44,152 $1,204 +9% 0.39%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$27.56 50 Officer, Director 63,650 2018-11-19 Filing
$27.56 3,600 Officer, Director 63,600 2018-11-19 Filing
$30.41 1,600 Officer 19,485 2018-06-13 Filing
$32.00 9,375 Large Shareholder 16,651 2018-02-22 Filing
$32.00 15,593 Large Shareholder, Director 22,869 2018-02-22 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$30.04 40,000 Officer 9,375 2018-11-19 Filing
$30.83 29,457 Officer, Director 315,308 2018-06-11 Filing
$30.70 42,106 Officer, Director 315,308 2018-06-08 Filing
$31.58 500 Officer, Director 315,308 2018-06-07 Filing
$30.95 32,098 Officer, Director 315,808 2018-06-07 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,300,797 $90,046 33.32%
2. 801,240 $21,858 4.82%
3. 189,857 $5,181 4.12%
4. 38,943 $1,062 2.27%
5. 1,739,000 $47,440 1.74%
News See All